New Englanders are driving and emitting more pollution every day. Emissions from New England’s transportation sector – the fastest growing emissions sector — produce about 40% of the total greenhouse gas emissions in the region, more than half of which comes from passenger cars. This is a problem for New England’s people, environment and economy.…
Boston University (BU) and the National Institutes of Health (NIH) are preparing a mandatory revised risk assessment for BU’s National Emerging Infectious Disease Laboratories (NEIDL), which has received substantial federal funding through NIH. I described the specifics of this risk assessment in an earlier post. The draft of that risk assessment is currently ready for…
CLF Applauds Springfield Zoning Board of Appeals Decision to Rescind Building Permits for Biomass-burning Plant in EJ Community
Late on Wednesday night residents of Springfield celebrated an important victory in their longstanding fight against a biomass-burning plant that Palmer Renewable Energy (PRE) proposes to construct in their community. Acting on the petition of local residents Michaelann Bewsee and Toni and William Keefe, the Springfield Zoning Board of Appeals (ZBA) overturned the two building permits that were issued to PRE last November. Media coverage of the ZBA decision is available here and here.
While much of Boston was distracted by the approaching holidays, public health and the environmental justice communities of Roxbury / South End scored a victory last Friday, December 23rd, when Secretary Sullivan issued his final decision to deny BU’s request to begin high level research at BU’s National Emerging Infectious Disease Laboratories (NEIDL) until a full risk assessment is reviewed by EOEEA.
There’s a common saying that if you can’t measure it, you can’t control it. Leaders of Boston University’s proposed National Emerging Infectious Diseases Laboratories (NEIDL) – known as the BU Biolab – in the densely populated urban Environmental Justice community of Roxbury/ South End, have asked the state to waive required review of their plans to build a lab involving rare and lethal pathogens even though their prior risk assessments were found inadequate multiple times. In other words, they want to build a risk laden facility without accountability to the public. We oppose the grant of this request.